跳至主要内容
临床试验/CTRI/2017/01/007686
CTRI/2017/01/007686已完成2 期

Assessment of short term effects of sildenafil therapy in patients with secondary pulmonary hypertension

Department of cardiology King george medical university0 个研究点目标入组 122 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
122

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with symptomatic secondary pulmonary hypertension with New York Heart Association (NYHA) functional class II-III with underlying aetiologies of pulmonary hypertension such as valvular heart disease, dilated cardiomyopathy, heart failure with preserved ejection fraction, chronic obstructive pulmonary disease and interstitial lung disease were included in the study.

排除标准

  • Patients with primary pulmonary hypertension, hypotension, allergy to sildenafil, ischemic heart disease, on other vasodilators (ex. Nitrate), prior treatment with other anti PAH drugs, prior cardiac valve surgery, severe valve stenosis were excluded from the study.

研究者

发起方
Department of cardiology King george medical university

相似试验